Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ibio Inc (NYSE MKT LLC:IBIO)

0.6223
Delayed Data
As of Aug 25
 -0.0079 / -1.25%
Today’s Change
0.45
Today|||52-Week Range
0.80
+11.12%
Year-to-Date
No recent news for Ibio Inc.

Today’s Trading

Previous close0.63
Today’s open0.63
Day’s range0.62 - 0.64
Volume227,301
Average volume (3 months)160,050
Market cap$56.2M
Dividend yield--
Data as of 08/25/2016

Growth & Valuation

Earnings growth (last year)-50.00%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+802.93%
P/E ratioNM
Price/Sales36.69
Price/Book4.33

Competitors

 Today’s
change
Today’s
% change
MTPMidatech Pharma PLC-0.29-7.23%
ISRIsoRay Inc0.000.00%
EVOKEvoke Pharma Inc-0.02-1.01%
CYANCyanotech Corp0.000.00%
Data as of 08/25/2016

Financials

Last reporting dateAugust 29, 2012
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$1.9M
Annual profit (last year)-$6.6M
Net profit margin-357.91%

Profile

Sector
Health Technology
Industry
Biotechnology
Executive Chairman &
Chief Executive Officer
Robert B. Kay
President
Robert L. Erwin
Corporate headquarters
Newark, Delaware

Forecasts

Partner Offers

Search for Jobs